Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by MilitaryManon Oct 16, 2016 12:09pm
333 Views
Post# 25348625

US Listing Requirement - Still not there yet

US Listing Requirement - Still not there yet
https://news.nationalpost.com/features/o-cannabis-corporate-cannabis#investors.S. investors eye Canada as testing ground

By Nick Eagland

VANCOUVER — As the U.S. takes a state-by-state approach to cannabis legalization, investors south of the border are pining for a chance to see how a market booms when national legalization arrives.

ArcView Market Research projects that in 2016, the legal market for cannabis in the United States will grow 26 per cent over last year, to US$7.1 billion, and will surpass US$22 billion by 2020.

Leslie Bocskor, founder and president of Las Vegas-based investment fund Electrum Partners, believes Canada is set to become a hub for the global cannabis industry, a place for research and development as well as a testing ground where U.S. firms can establish brands, knowledge and best practices before bringing them back home.

“You’ll probably see a lot of innovation in Canada,” Bocskor said. “[Canada] will become sort of the global centre with the largest economy and the best regulatory framework — the only regulatory framework — on a national basis with that kind of economy. Then that can become sort of the ‘Silicon Valley’ of cannabis, to a certain extent.”

Bocskor believes U.S. firms will choose to migrate their “best of breed” product categories, innovation, technology and methodology into Canada. Business issues solved in Canada can then be used in the U.S.

From Boskor’s perspective, Canada is already an environment conducive to doing cannabis business, with a large population and high cannabis consumption rates, a broad land mass and a good economy.

“It’s a clear and easy-to-navigate playing field in a very business-friendly environment that is going to be sort of changing the world with regards to policy on this issue,” he said. “I’m sure there’s an enormous section of the U.S. market that’s looking to do business in Canada.”

Bocskor believes legalization will present a great opportunity for Canadian and U.S. firms to collaborate. States with legalization, such as Colorado, Washington and Oregon, have cultivation processes that are “really pretty advanced” and large, experienced markets that he said have led to techniques, knowledge and intellectual property that will be important to migrate to the Canadian market.

“Canada will have an incredible opportunity in being federally legal before the United States, to adopt U.S. practices,” he said.

New York-based Tuatara Capital led a round of investments in Willie’s Reserve — musician Willie Nelson’s independent-grower-supplied cannabis firm — and Teewinot Life Sciences Corp., a firm developing cannabinoid-based therapies headquartered in Florida that conducts research in Manitoba.

Emily Paxhia is the managing director at Poseidon Asset Management, a San Francisco-based hedge fund focused on cannabis that recently invested in two licenced producers in Ontario.

“We’re in a constant state of research and seeking opportunities to fill up our pipeline for investing,” Paxhia said. “We really like the strategy of kind of covering North America and not just the United States, and ultimately we’re seeing this as a global investment opportunity. It just happens to be nice that our neighbour to the north is really digging in on this so that we can get up there, see things happening in person, and do the due diligence on the ground.”

Paxhia’s brother and founding partner at Poseidon, Morgan Paxhia, said that with Canada’s legal medical-cannabis system already in place, it has a “really solid foundation” for a regulated, good-quality market with strong institutional support.

“You’re just seeing the benefits of a true functioning market in Canada first, and hopefully we’ll see the U.S. catch up to that,” he said. “From an investor’s standpoint, it’s interesting to see because it is a really limited marketplace. From a production standpoint — there’s about 35 (licenced) producers to date in Canada — and in California there are thousands of producers for (a comparable) market size. So you can see these businesses scaling much faster and becoming much more stabilized because they are getting those economies of scale.”

Al Foreman, a partner and chief investment officer at Tuatara, said the firm’s current focus is on the next wave of expansion states: California, Arizona and Nevada.

But as the U.S. cannabis market remains fragmented because of state-by-state legalization, Canada’s position as the first national market “right out of the gate” has Tuatara’s attention, Foreman said.

“We’re watching the tone and pace of the legalization effort and believe that Canada is going to be an attractive market for investment dollars,” he said. “We believe that the Canadian efforts on the medical side have been a good kind of bellwether for a program done right and so, based on that, we would expect that federal legalization for adult use would follow a similar path.”

Postmedia News



https://www.investopedia.com/ask/answers/121.asp

A:

Major stock exchanges, like the Nasdaq, are exclusive clubs - their reputations rest on the companies they trade. As such, the Nasdaq won't allow just any company to be traded on its exchange. Only companies with a solid history and top-notch management behind them are considered.

The Nasdaq has three sets of listing requirements. Each company must meet at least one of the three requirement sets, as well as the main rules for all companies.

Listing Requirements for All Companies
Each company must have a minimum of 1,250,000 publicly-traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more then 10% of the company. In addition, the regular bid price at time of listing must be $4, and there must be at least three market makers for the stock. However, a company may qualify under a closing price alternative of $3 or $2 if the company meets varying reequirements. Each listing firm is also required to follow Nasdaq corporate governance rules 4350, 4351 and 4360. Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months.

In addition to these requirements, companies must meet all of the criteria under at least one of the following standards.

Listing Standard No. 1
The company must have aggregate pre-tax earnings in the prior three years of at least $11 million, in the prior two years at least $2.2 million, and no one year in the prior three years can have a net loss.

Listing Standard No. 2
The company must have a minimum aggregate cash flow of at least $27.5 million for the past three fiscal years, with no negative cash flow in any of those three years. In addition, its average market capitalization over the prior 12 months must be at least $550 million, and revenues in the previous fiscal year must be $110 million, minimum.

Listing Standard No. 3
Companies can be removed from the cash flow requirement of Standard No. 2 if the average market capitalization over the past 12 months is at least $850 million, and revenues over the prior fiscal year are at least $90 million.

A company has three ways to get listed on the Nasdaq, depending on the underlying fundamentals of the company. If a company does not meet certain criteria, such as the operating income minimum, it has to make it up with larger minimum amounts in another area like revenue. This helps to improve the quality of companies listed on the exchange.




Bullboard Posts